{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:47:03Z","timestamp":1790408823606,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100003757","name":"Foundation for the Advancement in Research in Medicine","doi-asserted-by":"publisher","award":["2000004198"],"award-info":[{"award-number":["2000004198"]}],"id":[{"id":"10.13039\/100003757","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health, National Center for Advancing Translational Sciences","award":["UL1TR001117"],"award-info":[{"award-number":["UL1TR001117"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      In 2012, seasonal malaria chemoprevention (SMC) was recommended as policy for malaria control by the World Health Organization (WHO) in areas of highly seasonal malaria transmission across the Sahel sub-region in Africa along with monitoring of drug resistance. We assessed the long-term impact of SMC on\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      resistance to sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) over a 3-year period of SMC implementation in the health district of Ouelessebougou, Mali.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In 8 randomly selected sub-districts of Ouelessebougou, Mali, children aged 0\u20135\u00a0years were randomly selected during cross-sectional surveys at baseline (August 2014) and 1, 2 and 3\u00a0years post-SMC, at the beginning and end of the malaria transmission season. Blood smears and blood spots on filter paper were obtained and frequencies of mutation in\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      genes related to resistance to SP and AQ (\n                      <jats:italic>Pfdhfr<\/jats:italic>\n                      ,\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      ,\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      , and\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      ) were assessed by PCR amplification on individual samples and PCR amplification followed by deep sequencing on pooled (by site and year) samples.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At each survey, approximately 50\u2013100 individual samples were analysed by PCR amplification and a total of 1,164 samples were analysed by deep sequencing with an average read depth of 18,018\u201336,918 after pooling by site and year. Most molecular markers of resistance did not increase in frequency over the period of study (2014\u20132016). After 3\u00a0years of SMC, the frequencies of\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      540E,\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      437G and\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      K76T remained similar compared to baseline (4.0\n                      <jats:italic>vs<\/jats:italic>\n                      1.4%, p\u2009=\u20090.41; 74.5\n                      <jats:italic>vs<\/jats:italic>\n                      64.6%, p\u2009=\u20090.22; 71.3\n                      <jats:italic>vs<\/jats:italic>\n                      67.4%, p\u2009=\u20090.69). Nearly all samples tested carried\n                      <jats:italic>Pfdhfr<\/jats:italic>\n                      59R, and this proportion remained similar 3\u00a0years after SMC implementation (98.8\n                      <jats:italic>vs<\/jats:italic>\n                      100%, p\u2009=\u20091). The frequency of\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86Y increased significantly over time from 5.6% at baseline to 18.6% after 3\u00a0years of SMC (p\u2009=\u20090.016). Results of pooled analysis using deep sequencing were consistent with those by individual analysis with standard PCR, but also indicated for the first time the presence of mutations at the\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      A581G allele at a frequency of 11.7% after 2\u00a0years of SMC, as well as the\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      I431V allele at frequencies of 1.6\u20139.3% following 1 and 2\u00a0years of SMC, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Two and 3\u00a0years of SMC implementation were associated with increased frequency of the\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      N86Y mutation but not\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      540E,\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      437G and\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      K76T. The first-time detection of the\n                      <jats:italic>Pfdhps<\/jats:italic>\n                      haplotype bearing the I431V and A581G mutations in Mali, even at low frequency, warrants further long-term surveillance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-022-04059-z","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T06:05:08Z","timestamp":1644300308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Effect of three years\u2019 seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali"],"prefix":"10.1186","volume":"21","author":[{"given":"Almahamoudou","family":"Mahamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey M.","family":"Sumner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandt","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliou","family":"Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadou","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djibrilla","family":"Issiaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adama B.","family":"Dembele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa B.","family":"Kanoute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumar","family":"Attaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubacar N.","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issaka","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulaye","family":"Djimde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick E.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve M.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alassane","family":"Dicko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"4059_CR1","unstructured":"WHO. World malaria report 2021. Geneva: World Health Organization, 2021. https:\/\/www.who.int\/malaria\/media\/world-malaria-report-2018\/en\/. Accessed 15 May 2021."},{"key":"4059_CR2","volume-title":"Seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa","author":"WHO","year":"2012","unstructured":"WHO. Seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization; 2012."},{"key":"4059_CR3","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization, 2019. https:\/\/www.who.int\/publications\/i\/item\/world-malaria-report-2019. Accessed 15 May 2021."},{"key":"4059_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000407","volume":"8","author":"A Dicko","year":"2011","unstructured":"Dicko A, Diallo AI, Tembine I, Dicko Y, Dara N, Sidibe Y, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8: e1000407.","journal-title":"PLoS Med"},{"key":"4059_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000408","volume":"8","author":"AT Konate","year":"2011","unstructured":"Konate AT, Yaro JB, Ouedraogo AZ, Diarra A, Gansane A, Soulama I, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8: e1000408.","journal-title":"PLoS Med"},{"key":"4059_CR6","unstructured":"WHO. Policy recommendation on intermittent preventive treatment during infancy with sulphadoxine-pyrimethamine (IPTi-SP) for Plasmodium falciparum malaria control in Africa. Geneva: World Health Organization; 2010. https:\/\/www.who.int\/malaria\/news\/WHO_policy_recommendation_IPTi_032010.pdf?ua=1. Accessed 15 May 2021."},{"key":"4059_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(18)30732-1","volume":"19","author":"AM van Eijk","year":"2019","unstructured":"van Eijk AM, Larsen DA, Kayentao K, Koshy G, Slaughter DEC, Roper C, et al. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19:546\u201356.","journal-title":"Lancet Infect Dis"},{"key":"4059_CR8","volume-title":"World malaria report","author":"WHO","year":"2020","unstructured":"WHO. World malaria report. Geneva: World Health Organization; 2020."},{"key":"4059_CR9","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/infdis\/jiu836","volume":"211","author":"J Gutman","year":"2015","unstructured":"Gutman J, Kalilani L, Taylor S, Zhou Z, Wiegand RE, Thwai KL, et al. The A581G mutation in the gene encoding Plasmodium falciparum dihydropteroate synthetase reduces the effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women. J Infect Dis. 2015;211:1997\u20132005.","journal-title":"J Infect Dis"},{"key":"4059_CR10","doi-asserted-by":"publisher","first-page":"e942","DOI":"10.1016\/S2214-109X(20)30119-4","volume":"8","author":"ME Roh","year":"2020","unstructured":"Roh ME, ter Kuile FO, Rerolle F, Glymour MM, Shiboski S, Gosling R, et al. Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis. Lancet Glob Health. 2020;8:e942\u201353.","journal-title":"Lancet Glob Health"},{"key":"4059_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ijpddr.2016.08.004","volume":"6","author":"MC Oguike","year":"2016","unstructured":"Oguike MC, Falade CO, Shu E, Enato IG, Watila I, Baba ES, et al. Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V. Int J Parasitol Drugs Drug Resist. 2016;6:220\u20139.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4059_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(20)32227-3","volume":"396","author":"ACCESS-SMC Partnership","year":"2020","unstructured":"ACCESS-SMC Partnership. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet. 2020;396:1829\u201340.","journal-title":"Lancet"},{"key":"4059_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12936-017-1974-x","volume":"16","author":"F Diawara","year":"2017","unstructured":"Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, et al. Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali. Malar J. 2017;16:325.","journal-title":"Malar J"},{"key":"4059_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003214","volume":"17","author":"ME Cairns","year":"2020","unstructured":"Cairns ME, Sagara I, Zongo I, Kuepfer I, Thera I, Nikiema F, et al. Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Hound\u00e9 district, Burkina Faso and Bougouni district, Mali. PLoS Med. 2020;17: e1003214.","journal-title":"PLoS Med"},{"key":"4059_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1475-2875-11-77","volume":"11","author":"AM McCollum","year":"2012","unstructured":"McCollum AM, Schneider KA, Griffing SM, Zhou Z, Kariuki S, ter Kuile F, et al. Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya. Malar J. 2012;11:77.","journal-title":"Malar J"},{"key":"4059_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193296","volume":"13","author":"A Barry","year":"2018","unstructured":"Barry A, Issiaka D, Traore T, Mahamar A, Diarra B, Sagara I, et al. Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: a cluster randomized trial. PLoS ONE. 2018;13: e0193296.","journal-title":"PLoS ONE"},{"key":"4059_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12936-017-1935-4","volume":"16","author":"A Mahamar","year":"2017","unstructured":"Mahamar A, Issiaka D, Barry A, Attaher O, Dembele AB, Traore T, et al. Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali. Malar J. 2017;16:289.","journal-title":"Malar J"},{"key":"4059_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","volume":"52","author":"CV Plowe","year":"1995","unstructured":"Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"4059_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimde","year":"2001","unstructured":"Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourt\u00e9 Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257\u201363.","journal-title":"N Engl J Med"},{"key":"4059_CR20","doi-asserted-by":"publisher","first-page":"41108","DOI":"10.1038\/srep41108","volume":"7","author":"B Levitt","year":"2017","unstructured":"Levitt B, Obala A, Langdon S, Corcoran D, O\u2019Meara WP, Taylor SM. Overlap extension barcoding for the next generation sequencing and genotyping of Plasmodium falciparum in individual patients in Western Kenya. Sci Rep. 2017;7:41108.","journal-title":"Sci Rep"},{"key":"4059_CR21","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","volume":"46","author":"E Afgan","year":"2018","unstructured":"Afgan E, Baker D, Batut B, van den Beek M, Bouvier D, Cech M, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 2018;46:W537\u201344.","journal-title":"Nucleic Acids Res"},{"key":"4059_CR22","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1038\/s41598-017-06708-9","volume":"7","author":"LC Okell","year":"2017","unstructured":"Okell LC, Griffin JT, Roper C. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci Rep. 2017;7:7389.","journal-title":"Sci Rep"},{"key":"4059_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003217","volume":"5","author":"F Amimo","year":"2020","unstructured":"Amimo F, Lambert B, Magit A, Sacarlal J, Hashizume M, Shibuya K. Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends. BMJ Global Health. 2020;5: e003217.","journal-title":"BMJ Global Health"},{"key":"4059_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002175","volume":"13","author":"B Ciss\u00e9","year":"2016","unstructured":"Ciss\u00e9 B, Ba EH, Sokhna C, NDiaye JL, Gomis JF, Dial Y, et al. Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: a stepped-wedge cluster-randomised trial. PLoS Med. 2016;13: e1002175.","journal-title":"PLoS Med"},{"key":"4059_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12936-020-03454-8","volume":"19","author":"MA Pacheco","year":"2020","unstructured":"Pacheco MA, Schneider KA, Cheng Q, Munde EO, Ndege C, Onyango C, et al. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H. Malar J. 2020;19:378.","journal-title":"Malar J"},{"key":"4059_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12936-018-2242-4","volume":"17","author":"RF Grais","year":"2018","unstructured":"Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, Langendorf C, et al. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger. Malar J. 2018;17:98.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04059-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04059-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04059-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T06:12:50Z","timestamp":1644300770000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04059-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4059"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04059-z","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"15 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol (Number 2014\/61\/CE\/FMPOS) and amendments were reviewed and approved by the Ethics Committee of the Faculty of Medicine, Pharmacy and Dentistry of the University of Bamako. Written informed consent from parents\/guardians was obtained for all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}